Dynamic Hydrogels for Probing Hepatic Stellate Cell Behavior During Fibrosis

用于探测纤维化过程中肝星状细胞行为的动态水凝胶

• 批准号: 8783331
• 负责人: Steven Caliari
• 金额: $ 4.99万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-01 至 2017-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8783331
• 关键词: Apoptosis; Biocompatible Materials; Biological Models; Cell Culture Techniques; Cell Differentiation process; Cells; Cessation of life; Chronic; Collagen; Collagen Type I; Cues; Deposition; Development; Disease; Disease model; Disease regression; Down-Regulation; Environment; Extracellular Matrix; Extracellular Matrix Proteins; Faculty; Fibroblasts; Fibrosis; Gel; Gene Expression; Genes; Glial Fibrillary Acidic Protein; Goals; Health; Heat shock proteins; Heavy Drinking; Hepatic; Hepatic Stellate Cell; Hepatitis; Hepatocyte; Hyaluronic Acid; Hydrogels; Hydrolysis; Injury; Kidney; Laboratories; Lipids; Liver; Liver Fibrosis; Liver diseases; Lung; Maintenance; Malignant Neoplasms; Matrix Metalloproteinases; Mechanics; Mediating; Methods; Modeling; Myofibroblast; Natural regeneration; Nature; Organ; Pancreas; Pathology; Pennsylvania; Pericytes; Phenotype; Plastics; Process; Production; Property; Research; Research Training; Retinoids; Rodent Model; Role; Scientist; Smooth Muscle Actin Staining Method; Source; System; Therapeutic Intervention; Time; Tissues; Transforming Growth Factors; Triad Acrylic Resin; Universities; Visible Radiation; Vitamin A; Werdnig-Hoffmann Disease; Work; Wound Healing; base; biophysical properties; career; cell behavior; combat; crosslink; cytokine; experience; fibrogenesis; improved; in vitro Model; in vivo; meetings; member; polyacrylamide; public health relevance; receptor; response; response to injury; therapeutic target; therapy development; tissue culture; tool; tumor growth

DESCRIPTION (provided by applicant): The differentiation of pericytes and fibroblasts to fibrogenic myofibroblasts is a common response to injury in many tissues, including the pancreas, lung, kidney, and liver. However, the persistence of myofibroblasts leads to excessive extracellular matrix (ECM) deposition and contraction, resulting in fibrosis and loss of organ function. Liver fibrosis is a serious health problem occurring in response to chronic insults, including hepatitis and excessive alcohol consumption. Hepatic stellate cells (HSCs) comprise ~ 15% of total resident liver cells and are also the primary source of hepatic myofibroblasts during fibrosis. With over 1.7 million deaths attributed to liver disease annually, extensive research is underway to better understand fibrosis progression and HSC myofibroblastic differentiation. Notably, there is growing appreciation for the role of local mechanical properties in regulating HSC activation, which is the focus of the proposed project. I propose that improved understanding of the microenvironmental cues that regulate HSC differentiation is critical to the development of therapies to combat liver fibrosis, and that biomaterials with controlled biophysical properties can be used as model systems to better probe the role of local mechanics on HSC behavior. Although initial studies in the Burdick and Wells laboratories have illustrated the influence of static material mechanics on HSC differentiation, there is still a gret need for dynamic material systems to mimic the evolving properties of native tissues. Therefore, the general objective of this proposal is to develop mechanically dynamic material systems based on hyaluronic acid (HA) to model HSC phenotypic changes during the progression and regression of fibrosis. The Burdick lab has a wealth of experience in developing tunable HA biomaterials and the Wells lab has expertise in liver mechanobiology and rodent models of liver fibrosis; thus, I am ideally suited to undertake the work proposed here. In Aim 1 I will develop hydrogels that stiffen over time to model the progression of fibrosis using secondary radical crosslinking that introduces additional crosslinks into an already formed hydrogel. I hypothesize that the rate of stiffening will determine the ultimate degree of myofibroblast differentiation and fibrogenesis, with more gradual stiffening leading to intermediate phenotypes. In Aim 2 I will develop hydrogels that soften over time via hydrolysis of crosslinks to model regression of fibrosis. I hypothesize that softening materials will yield HSCs with an intermediate phenotype similar to that observed in vivo during fibrosis regression and that the rate of softening will determine the ultimate phenotype. Together, the dynamic substrates developed here will be useful as streamlined models of other disease states in the wound healing-fibrosis-cancer triad and as ex vivo tools to identify potential targets for therapeutic intervention. Together, the proposed research and training plans in addition to the strong collaborative environment at the University of Pennsylvania will guide my development as a scientist and help me meet my career goal of becoming an independent faculty member.

描述（由申请人提供）：周细胞和成纤维细胞向成纤维性肌成纤维细胞的分化是许多组织损伤的常见反应，包括胰腺、肺、肾和肝。然而，肌成纤维细胞的持续存在导致过度的细胞外基质（ECM）沉积和收缩，导致纤维化和器官功能丧失。肝纤维化是一种严重的健康问题，是对慢性损伤的反应，包括肝炎和过度饮酒。肝星状细胞（HSCs）占总驻留肝细胞的15%左右，也是肝纤维化过程中肝肌成纤维细胞的主要来源。每年有超过170万人死于肝病，为了更好地了解纤维化进展和HSC肌成纤维细胞分化，广泛的研究正在进行中。值得注意的是，人们越来越认识到局部力学特性在调节HSC活化中的作用，这是拟议项目的重点。我提出，提高对调节HSC分化的微环境线索的理解对于对抗肝纤维化的治疗方法的发展至关重要，并且具有受控生物物理特性的生物材料可以用作模型系统，以更好地探索局部力学在HSC行为中的作用。尽管Burdick和Wells实验室的初步研究已经说明了静态材料力学对HSC分化的影响，但仍然非常需要动态材料系统来模拟天然组织的演变特性。因此，本提案的总体目标是开发基于透明质酸（HA）的机械动态材料系统，以模拟纤维化进展和消退过程中的HSC表型变化。Burdick实验室在开发可调血凝素生物材料方面拥有丰富的经验，Wells实验室在肝脏力学生物学和肝纤维化啮齿动物模型方面拥有专业知识；因此，我非常适合从事这里提出的工作。在目标1中，我将开发随着时间的推移而变硬的水凝胶，利用次生自由基交联将额外的交联引入已经形成的水凝胶来模拟纤维化的进展。我推测硬化的速率将决定肌成纤维细胞分化的最终程度